Original Article

You have full text access to this OnlineOpen article

Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: Establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity†

  1. Melissa G. Lechner BA1,
  2. Stephen Lade MD2,
  3. Daniel J. Liebertz MD1,
  4. H. Miles Prince MD2,
  5. Garry S. Brody MD3,
  6. Howard R. Webster MD4,
  7. Alan L. Epstein MD, PhD1,‡,*

Article first published online: 8 NOV 2010

DOI: 10.1002/cncr.25654

Issue

Cancer

Cancer

Volume 117, Issue 7, pages 1478–1489, 1 April 2011

Additional Information

How to Cite

Lechner, M. G., Lade, S., Liebertz, D. J., Prince, H. M., Brody, G. S., Webster, H. R. and Epstein, A. L. (2011), Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: Establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity. Cancer, 117: 1478–1489. doi: 10.1002/cncr.25654

Author Information

  1. 1

    Pathology Department, USC Keck School of Medicine, Los Angeles, California

  2. 2

    Division of Hematology and Medical Oncology, Peter MacCallum Cancer Center, University of Melbourne, Victoria, Australia

  3. 3

    Plastic Surgery Department, University of Southern California Keck School of Medicine, Los Angeles, California

  4. 4

    ARC Plastic Surgery, University of Melbourne, Victoria, Australia

  1. ‡

    Fax: (323) 442-3049

*Pathology Department, Hoffman Medical Research Building Room 205, USC Keck School of Medicine, Los Angeles, CA 90033

  1. †

    M.G.L. characterized the TLBR-1 cell line, analyzed the data, and wrote the article. S.L., H.M.P., and H.R.W. provided clinical care and management of the patient, performed clinical studies on the original biopsy specimen, and wrote the case report. D.J.L. assisted with polymerase chain reaction (PCR) and qRT-PCR analyses and prepared the figures. G.S.B. identified the patient and arranged for transport of the biopsy specimen. A.L.E. established the cell line and supervised the studies. All authors reviewed the manuscript.

Publication History

  1. Issue published online: 18 MAR 2011
  2. Article first published online: 8 NOV 2010
  3. Manuscript Accepted: 9 AUG 2010
  4. Manuscript Revised: 22 JUN 2010
  5. Manuscript Received: 22 MAR 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (747K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Richard C. Cabot, Nancy Lee Harris, Jo-Anne O. Shepard, Eric S. Rosenberg, Alice M. Cort, Sally H. Ebeling, Christine C. Peters, Darrell N. Kotton, Victorine V. Muse, Michiya Nishino, Case 2-2012, New England Journal of Medicine, 2012, 366, 3, 259

    CrossRef

  2. 2
    J. Mychaluk, D. Perignon, Q. Qassemyar, M. Gianfermi, R. Sinna, Prothèse mammaire et lymphome T anaplasique à grandes cellules : que savons-nous ?, Annales de Chirurgie Plastique Esthétique, 2012, 57, 1, 1

    CrossRef

  3. 3
    Davide Lazzeri, Tommaso Agostini, Guido Bocci, Giordano Giannotti, Giovanni Fanelli, Antonio Giuseppe Naccarato, Romano Danesi, Marco Tuccori, Marcello Pantaloni, Carlo D'Aniello, ALK-1–Negative Anaplastic Large Cell Lymphoma Associated With Breast Implants: A New Clinical Entity, Clinical Breast Cancer, 2011, 11, 5, 283

    CrossRef

  4. 4
    Leslie Popplewell, Sandra H. Thomas, Qin Huang, Karen L. Chang, Stephen J. Forman, Primary anaplastic large-cell lymphoma associated with breast implants, Leukemia & Lymphoma, 2011, 52, 8, 1481

    CrossRef

  5. 5
    Sarah M. Russell, Melissa G. Lechner, Lucy Gong, Carolina Megiel, Daniel J. Liebertz, Rizwan Masood, Adrian J. Correa, Jing Han, Raj K. Puri, Uttam K. Sinha, Alan L. Epstein, USC-HN2, a new model cell line for recurrent oral cavity squamous cell carcinoma with immunosuppressive characteristics, Oral Oncology, 2011, 47, 9, 810

    CrossRef

View Full Article (HTML) Get PDF (747K)